When asked if it's true that venture capital investors are no longer interested in funding very early-stage life science companies, Venrock Partner Camille Samuels told Biocom's recent Global Life Science Partnering Conference that "I think it's hogwash," because "we absolutely are interested."
But while multiple speakers on a Feb. 28 panel on the future of venture investing insisted that they're ready, willing...






